BAMCO Inc’s Intersect ENT, Inc XENT Stock Holding History

BAMCO Inc’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-90,000	Closed	-$2.24M	–	368
2019 Q4	$2.24M	Hold	90,000	–	–	0.01%	285
2019 Q3	$1.53M	Sell	90,000 -100,000	-53%	-$1.82M	0.01%	285
2019 Q2	$4.32M	Sell	190,000 -206,288	-52%	-$5.56M	0.02%	268
2019 Q1	$12.7M	Buy	396,288 +638	+0.2%	+$19.7K	0.05%	191
2018 Q4	$11.1M	Buy	395,650 +2,314	+0.6%	+$67.8K	0.06%	188
2018 Q3	$11.3M	Buy	393,336 +296,336	+306%	+$8.9M	0.05%	199
2018 Q2	$3.63M	Buy	97,000 +25,000	+35%	+$981K	0.02%	256
2018 Q1	$2.83M	Buy	+72,000	New	+$2.63M	0.01%	258
2015 Q4	–	Sell	-55,000	Closed	-$1.29M	–	336
2015 Q3	$1.29M	Sell	55,000 -9,000	-14%	-$248K	0.01%	293
2015 Q2	$1.83M	Sell	64,000 -24,536	-28%	-$643K	0.01%	305
2015 Q1	$2.29M	Sell	88,536 -10,000	-10%	-$229K	0.01%	293
2014 Q4	$1.83M	Buy	98,536 +21,008	+27%	+$378K	0.01%	295
2014 Q3	$1.2M	Buy	+77,528	New	+$1.17M	0.01%	313

Other funds holding XENT

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BAMCO Inc's XENT Position: Q1 2020 in Review

BAMCO Inc sold out of Intersect ENT, Inc (XENT) in Q1 2020, closing a stake of 90,000 shares — an estimated $2.24M sold.

BAMCO Inc first reported a position in XENT in Q3 2014 and held it in 13 quarters. The position peaked at $12.7M in Q1 2019. 121 funds tracked by Wall St. Rank hold XENT as of Q1 2020.

BAMCO Inc reported no remaining Intersect ENT, Inc position as of Q1 2020 after selling out during the quarter.
BAMCO Inc sold 90,000 Intersect ENT, Inc shares in Q1 2020, an estimated $2.24M.
BAMCO Inc first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 13 quarters.
BAMCO Inc's Intersect ENT, Inc position peaked at $12.7M in Q1 2019.
121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2020.

Based on BAMCO Inc's 13F filing for Q1 2020, filed 15 May 2020.